Published in Eur J Biochem on March 01, 1971
The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol (1978) 6.03
The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med (1973) 4.74
Similarities of the anti-tumour actions of endotoxin, lipid A and double-stranded RNA. Br J Cancer (1973) 4.65
Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process. J Exp Med (1974) 4.45
The use of bacterial lipopolysaccharides to show that two signals are required for the induction of antibody synthesis. J Exp Med (1973) 2.30
Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ Mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS. J Exp Med (1975) 2.22
Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun (1980) 1.85
Insect immunity. I. Characteristics of an inducible cell-free antibacterial reaction in hemolymph of Samia cynthia pupae. Infect Immun (1974) 1.78
Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization. Infect Immun (1979) 1.68
Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway. J Exp Med (1976) 1.64
Isolation from human serum of an inactivator of bacterial lipopolysaccharide. Am J Pathol (1977) 1.58
Purification of extracellular lipase from Pseudomonas aeruginosa. J Bacteriol (1986) 1.58
Induction of inflammation by Escherichia coli on the mucosal level: requirement for adherence and endotoxin. Infect Immun (1988) 1.56
Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants. Infect Immun (1977) 1.56
Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B. Infect Immun (1976) 1.53
Protective role of smooth lipopolysaccharide in the serum bactericidal reaction. Infect Immun (1971) 1.49
Protection against gram-negative infections with antiserum to lipid A from Salmonella minnesota R595. Infect Immun (1974) 1.47
Chemical and immunological analysis of the complex structure of Escherichia coli alpha-hemolysin. J Bacteriol (1985) 1.46
Macrophage activation by monosaccharide precursors of Escherichia coli lipid A. Proc Natl Acad Sci U S A (1985) 1.39
Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun (1973) 1.38
Escherichia coli lipopolysaccharides diminish and enhance cell function of human polymorphonuclear leukocytes. Infect Immun (1983) 1.35
Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest (1992) 1.35
Endotoxin in vitro interactions with human neutrophils: depression of chemiluminescence, oxygen consumption, superoxide production, and killing. Infect Immun (1979) 1.32
Activation of complement by opportunist pathogens and chemotypes of Salmonella minnesota. Infect Immun (1977) 1.32
Characterization of endotoxin from Fusobacterium necrophorun. Infect Immun (1975) 1.26
Biological activities of fragments derived from Bordetella pertussis endotoxin: isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties. Infect Immun (1980) 1.25
Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis. Infect Immun (1977) 1.23
Lipid A and anti-lipid A. Infect Immun (1979) 1.23
Macrophage stimulation by bacterial lipopolysaccharides. II. Evidence for differentiation signals delivered by lipid A and by a protein rich fraction of lipopolysaccharides. J Exp Med (1978) 1.22
Immunobiological activities of synthetic lipid A analogs and related compounds as compared with those of bacterial lipopolysaccharide, re-glycolipid, lipid A, and muramyl dipeptide. Infect Immun (1983) 1.19
Studies of lipid A fractions from the lipopolysaccharides of Pseudomonas aeruginosa and Pseudomonas alcaligenes. Biochem J (1973) 1.19
Nature, type of linkage, and absolute configuration of (hydroxy) fatty acids in lipopolysaccharides from Xanthomonas sinensis and related strains. J Bacteriol (1975) 1.16
Role of lipopolysaccharide in the receptor function for bacteriophage TuIb in Escherichia coli. J Bacteriol (1981) 1.15
Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency. Immunology (1973) 1.13
Evidence for two immune inhibitors from Bacillus thuringiensis interfering with the humoral defense system of saturniid pupae. Infect Immun (1976) 1.12
Biological effects of the interaction of staphylococcal alpha-toxin with human serum. Infect Immun (1982) 1.11
Localization and biological and physicochemical properties of the cell wall lipopolysaccharide of Rhodopseudomonas capsulata. J Bacteriol (1972) 1.08
Biological and physicochemical properties of the lipopolysaccharide of Chromatium vinosum. Infect Immun (1977) 1.05
Comparative studies on adjuvanticity of Klebsiella O3 lipopolysaccharide and its lipid A and polysaccharide fractions. Immunology (1985) 1.04
Biological and chemical characterization of endotoxin from Capnocytophaga sputigena. Infect Immun (1980) 1.02
Mechanisms of lipopolysaccharide-initiated rabbit platelet responses: alternative complement pathway dependence of the lytic response. Infect Immun (1978) 1.01
Chemical structure of the lipid A component of lipopolysaccharides from Fusobacterium nucleatum. J Bacteriol (1977) 0.99
Arrangement of bacteriophage lambda receptor protein (LamB) in the cell surface of Escherichia coli: a reconstitution study. J Bacteriol (1981) 0.99
Interaction of lipopolysaccharides and lipid A with complement in rats and its relation to endotoxicity. Infect Immun (1978) 0.99
Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells. J Clin Invest (1977) 0.97
Formation of prostanoids during intravascular complement activation in the rabbit. Br J Pharmacol (1985) 0.97
Induction of human granulocyte chemiluminescence by bacterial lipopolysaccharides. Infect Immun (1987) 0.97
Bacteroidaceae in thromboembolic disease: effects of cell wall components on blood coagulation in vivo and in vitro. Infect Immun (1973) 0.94
Neutrophil adherence induced by lipopolysaccharide in vitro. Role of plasma component interaction with lipopolysaccharide. J Clin Invest (1992) 0.93
Human complement activation by lipopolysaccharides from bacteroides oralis, fusobacterium nucleatum, and veillonella parvula. Infect Immun (1979) 0.93
Interaction between endotoxin and human monocytes: characteristics of the binding of 3H-labeled lipopolysaccharide and 51Cr-labeled lipid A before and after the induction of endotoxin tolerance. Proc Natl Acad Sci U S A (1984) 0.93
Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients. J Clin Microbiol (1992) 0.90
Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin. Infect Immun (1993) 0.90
Acinetobacter and E. coli lipopolysaccharide preparations comparative mitogenicity and induction in vitro of immunoglobulin synthesis in adult and neonatal pig lymphocytes. Immunology (1979) 0.89
Effect of lipopolysaccharide and lipid A on mouse liver pyruvate kinase activity. Infect Immun (1975) 0.85
Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14. Infect Immun (1999) 0.83
Anticomplementary activity of tuberculin: relationship to platelet aggregation and lytic response. Infect Immun (1979) 0.83
Isolation and characterization of a cross-reacting antigen in strains of Bacteroidaceae. Infect Immun (1982) 0.81
Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system. Infect Immun (1977) 0.80
Characteristics of lipid A-protein complex from endotoxin of Shigella dysenteriae type 1 (S and R strains). Infect Immun (1979) 0.80
Projected structure of the pore-forming OmpC protein from Escherichia coli outer membrane. Biophys J (1985) 0.80
Interferon production in mice by components of Salmonella minnesota R595 lipid A. Infect Immun (1976) 0.79
Kinetics of B-lymphocytes stimulation by pokeweed Pa-1 mitogen and bacterial lipopolysaccharide. Immunology (1979) 0.78
Evidence from a carbohydrate incorporation assay for direct activation of bone marrow myelopoietic precursor cells by bacterial cell wall constitutents. Infect Immun (1981) 0.77
Stimulation of phagocytic activity in the reticuloendothelial systems of mice by lipid A complexed with homologous or heterologous proteins. Infect Immun (1975) 0.77
Local skin response in mice induced by a single intradermal injection of bacterial lipopolysaccharide and lipid A. Infect Immun (1991) 0.76
Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines. Sci Rep (2016) 0.76
Effect on particle size of solubilization of wild-type and Re chemotype lipopolysaccharides solubilized with bovine serum albumin and triethylamine. Infect Immun (1978) 0.75
Biological and physicochemical characteristics of four serotypes of Salmonella enteritidis. Infect Immun (1978) 0.75
On the pyrogenic action of intravenous lipid A in rabbits. J Physiol (1982) 0.75
L-rhamnose inhibits proliferation of murine splenocytes by the lipopolysaccharide and polysaccharide moiety of Shigella dysenteriae type 1 lipopolysaccharide. Immunology (1995) 0.75
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science (1998) 37.15
A new method for the extraction of R lipopolysaccharides. Eur J Biochem (1969) 22.41
Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae. Bacteriol Rev (1966) 13.42
Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A (1979) 6.77
Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur J Biochem (1975) 5.29
The mitogenic effect of lipopolysaccharide on bone marrow-derived mouse lymphocytes. Lipid A as the mitogenic part of the molecule. J Exp Med (1973) 4.74
Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med (1987) 4.63
Picogram-sensitive assay for endotoxin: gelation of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharides and lipid A from Gram-negative bacteria. Biochim Biophys Acta (1972) 4.45
Nature and linkages of the fatty acids present in the lipid-A component of Salmonella lipopolysaccharides. Eur J Biochem (1972) 4.15
Structural investigations on the 2-keto-3-deoxyoctonate region of lipopolysaccharides. Eur J Biochem (1970) 4.14
Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. Eur J Biochem (1971) 4.01
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem (1985) 3.76
The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen. J Exp Med (1975) 3.55
Structural relationship of Salmonella O and R antigens. Ann N Y Acad Sci (1966) 3.54
Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res (2001) 3.46
Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun (1986) 3.42
Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal). Zentralbl Bakteriol Orig A (1979) 3.08
Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem (1972) 3.04
Synthesis and use of O-stearoyl polysaccharides in passive hemagglutination and hemolysis. Eur J Biochem (1967) 2.99
Biochemical studies on lipopolysaccharides of Salmonella R mutants. 6. Investigations on the structure of the lipid A component. Eur J Biochem (1969) 2.93
Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett (1981) 2.91
IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol (1989) 2.41
Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect Immun (1991) 2.34
A lethal role for lipid A in Salmonella infections. Mol Microbiol (1998) 2.30
Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun (1988) 2.23
[Immunochemical studies of K antigens from Escherichia coli. II. K antigen from E. coli 08:K42(A):H-]. Biochem Z (1965) 2.20
Differential determination of the 3-Deoxy-D-mannooctulosonic acid residues in lipopolysaccharides of Salmonella minnesota rough mutants. Eur J Biochem (1983) 2.12
Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. J Immunol (1983) 2.06
Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels. J Clin Microbiol (1990) 2.02
Molecular mechanisms of endotoxin activity. Arch Microbiol (1995) 1.98
Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture. Int Arch Allergy Appl Immunol (1975) 1.97
A new gene cluster rfe concerned with the biosynthesis of Salmonella lipopolysaccharide. J Gen Microbiol (1970) 1.91
Isolation and analysis of the lipid A backbone. Lipid A structure of lipopolysaccharides from various bacterial groups. Eur J Biochem (1976) 1.87
Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins. Prog Allergy (1983) 1.86
Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem (2000) 1.85
High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J Bacteriol (1985) 1.85
Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun (1980) 1.85
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype. Eur J Biochem (1988) 1.73
Lipid A: chemical structure and biological activity. J Infect Dis (1973) 1.73
Diurnal variations in the human host response to endotoxin. J Infect Dis (1996) 1.71
Chemical structure and biological activities of lipid A's from various bacterial families. Naturwissenschaften (1978) 1.69
The chemical structure of lipid A. Demonstration of amide-linked 3-acyloxyacyl residues in Salmonella minnesota Re lipopolysaccharide. Eur J Biochem (1982) 1.67
The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anti-complementary activity. Eur J Biochem (1976) 1.64
Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun (1992) 1.61
Studies on the structure of lipopolysaccharides of Salmonella minnesota and Salmonella typhimurium R strains. Biochem J (1965) 1.60
Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun (1994) 1.59
Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun (1984) 1.59
Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis Suppl (1982) 1.56
Physical state and biological activity of lipopolysaccharides. Toxicity and immunogenicity of the lipid A component. Z Immunitatsforsch Exp Klin Immunol (1975) 1.55
[Investigations on the Typing of salmonella R-forms. IV. Typing of S. minnesota-R-mutants by antibiotics]. Zentralbl Bakteriol Orig (1970) 1.55
Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence. FEBS Lett (1978) 1.55
Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant. Eur J Biochem (1983) 1.54
Time course of cellular distribution of endotoxin in liver, lungs and kidneys of rats. Br J Exp Pathol (1982) 1.54
Daily subcutaneous administration of human growth hormone in growth hormone deficient children. Acta Paediatr Scand (1986) 1.53
Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect Immun (1999) 1.52
Immunogenic properties of lipid A. Rev Infect Dis (1984) 1.51
The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect Immun (1987) 1.49
A lipopolysaccharide-binding cell-surface protein from Salmonella minnesota. Isolation, partial characterization and occurrence in different Enterobacteriaceae. Eur J Biochem (1979) 1.49
[Growth and lipopolysaccharide (O-antigen) levels of salmonella in cultures of agar media]. Zentralbl Bakteriol Orig (1966) 1.49
A new class of heptose-defective mutant of Salmonella typhimurium. Eur J Biochem (1973) 1.48
Composition of lipopolysaccharides from Myxococcus fulvus and other fruiting and non-fruiting myxobacteria. Eur J Biochem (1974) 1.46
Structural characterization of the lipid A component of pathogenic Neisseria meningitidis. J Bacteriol (1992) 1.46